Combining Gold Nanoparticles with Other Radiosensitizing Agents for Unlocking the Full Potential of Cancer Radiotherapy

About half of cancer patients (50%) receive radiotherapy (RT) for the treatment of local tumors. However, one of the main obstacles in RT is the close proximity of adjacent organs at risk, resulting in treatment doses being limited by significant tissue toxicity, hence preventing the necessary dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhussan, Abdulaziz, Bozdoğan, Ece Pinar Demirci, Chithrani, Devika B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064393/
https://www.ncbi.nlm.nih.gov/pubmed/33805917
http://dx.doi.org/10.3390/pharmaceutics13040442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064393/
https://www.ncbi.nlm.nih.gov/pubmed/33805917
http://dx.doi.org/10.3390/pharmaceutics13040442

Ejemplares similares